Gagliardi S - Search Results

1

Novel bone antiresorptive agents that selectively inhibit the osteoclast V-H+-ATPase.

Farina C, Gagliardi S, Nadler G, Morvan M, Parini C, Belfiore P, Visentin L, Gowen M. Farina C, et al. Among authors: gagliardi s. Farmaco. 2001 Jan-Feb;56(1-2):113-6. doi: 10.1016/s0014-827x(01)01013-8. Farmaco. 2001. PMID: 11347950 Review.

2

Synthesis of photoactivable inhibitors of osteoclast vacuolar ATPase.

Biasotti B, Dallavalle S, Merlini L, Farina C, Gagliardi S, Parini C, Belfiore P. Biasotti B, et al. Among authors: gagliardi s. Bioorg Med Chem. 2003 May 15;11(10):2247-54. doi: 10.1016/s0968-0896(03)00106-8. Bioorg Med Chem. 2003. PMID: 12713834

3

Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase.

Gagliardi S, Gatti PA, Belfiore P, Zocchetti A, Clarke GD, Farina C. Gagliardi S, et al. J Med Chem. 1998 May 21;41(11):1883-93. doi: 10.1021/jm9707838. J Med Chem. 1998. PMID: 9599238

4

(2Z,4E)-5-(5,6-dichloro-2-indolyl)-2-methoxy-N-(1,2,2,6,6- pentamethylpiperidin-4-yl)-2,4-pentadienamide, a novel, potent and selective inhibitor of the osteoclast V-ATPase.

Nadler G, Morvan M, Delimoge I, Belfiore P, Zocchetti A, James I, Zembryki D, Lee-Rycakzewski E, Parini C, Consolandi E, Gagliardi S, Farina C. Nadler G, et al. Among authors: gagliardi s. Bioorg Med Chem Lett. 1998 Dec 15;8(24):3621-6. doi: 10.1016/s0960-894x(98)00660-x. Bioorg Med Chem Lett. 1998. PMID: 9934482

5

Selective inhibitors of the osteoclast vacuolar proton ATPase as novel bone antiresorptive agents.

Farina C, Gagliardi S. Farina C, et al. Among authors: gagliardi s. Drug Discov Today. 1999 Apr;4(4):163-172. doi: 10.1016/S1359-6446(99)01321-5. Drug Discov Today. 1999. PMID: 10322275

6

Chemistry and structure activity relationships of bafilomycin A1, a potent and selective inhibitor of the vacuolar H+-ATPase.

Gagliardi S, Rees M, Farina C. Gagliardi S, et al. Curr Med Chem. 1999 Dec;6(12):1197-212. Curr Med Chem. 1999. PMID: 10519916 Review.

7

Selective inhibition of osteoclast vacuolar H(+)-ATPase.

Farina C, Gagliardi S. Farina C, et al. Among authors: gagliardi s. Curr Pharm Des. 2002;8(23):2033-48. doi: 10.2174/1381612023393369. Curr Pharm Des. 2002. PMID: 12171517 Review.

8

5-(5,6-Dichloro-2-indolyl)-2-methoxy-2,4-pentadienamides: novel and selective inhibitors of the vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity.

Gagliardi S, Nadler G, Consolandi E, Parini C, Morvan M, Legave MN, Belfiore P, Zocchetti A, Clarke GD, James I, Nambi P, Gowen M, Farina C. Gagliardi S, et al. J Med Chem. 1998 May 7;41(10):1568-73. doi: 10.1021/jm9800144. J Med Chem. 1998. PMID: 9572882

9

Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists.

Giardina GA, Artico M, Cavagnera S, Cerri A, Consolandi E, Gagliardi S, Graziani D, Grugni M, Hay DW, Luttmann MA, Mena R, Raveglia LF, Rigolio R, Sarau HM, Schmidt DB, Zanoni G, Farina C. Giardina GA, et al. Among authors: gagliardi s. Farmaco. 1999 Jun 30;54(6):364-74. doi: 10.1016/s0014-827x(99)00043-9. Farmaco. 1999. PMID: 10443017

10

Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-atpases.

Boyd MR, Farina C, Belfiore P, Gagliardi S, Kim JW, Hayakawa Y, Beutler JA, McKee TC, Bowman BJ, Bowman EJ. Boyd MR, et al. Among authors: gagliardi s. J Pharmacol Exp Ther. 2001 Apr;297(1):114-20. J Pharmacol Exp Ther. 2001. PMID: 11259534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters